Skip to content

Group psychotherapy in patients with borderline personality disorder: experimental contribution in an outpatient setting

Group psychotherapy in patients with borderline personality disorder: investigating the effect on symptoms when delivered in an outpatient setting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12623000002684
Enrollment
58
Registered
2023-01-09
Start date
2022-04-22
Completion date
2025-04-22
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Psychotherapy appears to be the pivotal treatment for patients with DBP. In particular, the interpersonal psychotherapeutic approach appears particularly suitable for this type of patient because it acts on the dysfunctional relational patterns that represent the core of the disorder. The group approach can be an opportunity for the borderline patient to experience his or her own relational dynamics in a protected environment; it allows patients to realise that others share their illness; it facilitates self-reflection and understanding of how certain behaviours provoke particular reactions; it gives the possibility of directly testing certain changes within the group and receiving in return support and stimulation in bringing these changes into one's relational life, of feeling gratified when helping other group members. At the same time, the group context offers therapists the possibility of treating a larger number of patients simultaneously while optimising costs and time. As the current literature on IPT-G in DBP is scarce, the results of this study could provide useful new evidence and inspire the launch of an outpatient project to be shared with other clinics, both hospital and territorial.

Interventions

The aim of the trial is to evaluate the effectiveness of interpersonal group psychotherapy in patients with Borderline Personality Disorder (BPD) on the main symptom clusters of the disorder, anxiety and depressive symptoms, global functioning and quality of life. The interpersonal group psychotherapeutic approach will be compared with individual interpersonal psychotherapy alone. Interventions: 1) 20 minute one-on-one interview with the registered psychiatrist for the presentation of the pro

The aim of the trial is to evaluate the effectiveness of interpersonal group psychotherapy in patients with Borderline Personality Disorder (BPD) on the main symptom clusters of the disorder, anxiety and depressive symptoms, global functioning and quality of life. The interpersonal group psychotherapeutic approach will be compared with individual interpersonal psychotherapy alone. Interventions: 1) 20 minute one-on-one interview with the registered psychiatrist for the presentation of the project, 2 week prior to the first group session; 2) 16 interpersonal group psychotherapy meetings lasting 60 minutes delivered once a week; sessions include a first part in which participants take turns exposing the most important events of the past week. In the second part, they decide which situation to analyze collectively. the maximum number of participants who may attend a group session is 10 participants together with the psychiatrist, psychologist and two residents. To monitor treatment adherence, a satisfaction questionnaire is administered at the end of each session. 3) 90-minute clinical interviews with administration of psychometric scales at (t0 and t1). The sessions will be held by a psychiatrist, in the presence of a psychologist and two residents.

Sponsors

University of Turin
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Consecutive (18-60 years), outpatients with a diagnosis of DBP according to DSM-5 criteria will be enrolled. The diagnosis is made by evaluation by experienced clinicians and by administration of SCID-5 (Structured Clinical Interview for DSM-5 personality disorders). The patients in this group are undergoing individual interpersonal psychotherapy, which will be supported by IPT-G intervention.

Exclusion criteria

a) presence of neuropsychiatric comorbidities, assessed according to DSM-5 criteria and including: neurodevelopmental disorders; neurocognitive disorders; schizophrenia and schizophrenic spectrum disorders; bipolar disorder b) concomitant major depressive episode and/or active substance use; c) symptomatological severity judged by the clinician to be incompatible with adaptation to the group setting.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 8, 2026